Revvity, Inc. (RVTY)
(Delayed Data from NYSE)
$102.01 USD
-0.99 (-0.96%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $102.02 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RVTY 102.01 -0.99(-0.96%)
Will RVTY be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for RVTY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RVTY
Why Is Pediatrix Medical Group (MD) Down 15.9% Since Last Earnings Report?
Cencora (COR) Down 1.9% Since Last Earnings Report: Can It Rebound?
RVTY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now
Company News for Apr 30, 2024
Revvity (RVTY) Q1 Earnings and Revenues Surpass Estimates
Other News for RVTY
Barclays Sticks to Their Hold Rating for Revvity (RVTY)
Revvity price target lowered by $1 at Barclays, here's why
Bionano Announces Software Marketing Agreement with Revvity for Newborn Sequencing Research
Bionano Genomics enters software marketing agreement with Revvity
Revvity assumed with a Hold at Jefferies